Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1165 Eastlake Ave E, Seattle, WA
State of incorporation
WA
Fiscal year end
December 31
Former names
Adaptive TCR Corp (to 6/2/2011)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 417 % -18.1%
Quick Ratio 15.3 % -18.5%
Debt-to-equity 131 % +45.6%
Return On Equity -74.5 % -56.5%
Return On Assets -32.2 % -28.6%
Operating Margin -113 % -3.77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 148M shares +1.94%
Common Stock, Shares, Outstanding 148M shares +1.93%
Entity Public Float 756M USD -15.9%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 148M shares +1.94%
Weighted Average Number of Shares Outstanding, Diluted 148M shares +1.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 177M USD -1.34%
Research and Development Expense 109M USD -12.9%
Selling and Marketing Expense 85.1M USD -5.86%
General and Administrative Expense 75.5M USD -11.9%
Costs and Expenses 377M USD +0.59%
Operating Income (Loss) -200M USD -2.37%
Net Income (Loss) Attributable to Parent -195M USD +0.36%
Earnings Per Share, Basic -1.34 USD/shares +0.74%
Earnings Per Share, Diluted -1.34 USD/shares +0.74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.1M USD -57.1%
Accounts Receivable, after Allowance for Credit Loss, Current 40.8M USD +30.8%
Inventory, Net 12M USD -38.7%
Assets, Current 308M USD -29.2%
Property, Plant and Equipment, Net 51.3M USD -33.1%
Operating Lease, Right-of-Use Asset 46.5M USD -38.2%
Goodwill 119M USD 0%
Other Assets, Noncurrent 2.65M USD -11.2%
Assets 559M USD -22.2%
Accounts Payable, Current 7.35M USD +64%
Employee-related Liabilities, Current 12.3M USD +15.9%
Accrued Liabilities, Current 6.06M USD -40.3%
Contract with Customer, Liability, Current 51.9M USD -6.3%
Liabilities, Current 87.6M USD -6.08%
Contract with Customer, Liability, Noncurrent 32.8M USD -25.8%
Operating Lease, Liability, Noncurrent 81.8M USD -10.9%
Other Liabilities, Noncurrent 20K USD
Liabilities 335M USD -5.93%
Accumulated Other Comprehensive Income (Loss), Net of Tax 497K USD
Retained Earnings (Accumulated Deficit) -1.27B USD -18.2%
Stockholders' Equity Attributable to Parent 224M USD -38.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 224M USD -38.2%
Liabilities and Equity 559M USD -22.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.4M USD +35.2%
Net Cash Provided by (Used in) Financing Activities 44K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 44.5M USD -29.3%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 148M shares +1.93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.2M USD +37.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.29M USD -17.1%
Deferred Tax Assets, Valuation Allowance 402M USD +16.1%
Deferred Tax Assets, Gross 417M USD +12.2%
Operating Lease, Liability 91.8M USD -9.36%
Depreciation 4.79M USD -4.26%
Payments to Acquire Property, Plant, and Equipment 1.51M USD -48.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -194M USD -2.25%
Lessee, Operating Lease, Liability, to be Paid 111M USD -11.1%
Property, Plant and Equipment, Gross 141M USD +2.66%
Operating Lease, Liability, Current 10M USD +5.68%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.1M USD +2.97%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.3M USD -18.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.9M USD -3.13%
Deferred Tax Assets, Operating Loss Carryforwards 252M USD +19.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.3M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.3M USD +2.83%
Operating Lease, Payments 3.7M USD +8.82%
Additional Paid in Capital 1.49B USD +3.94%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD +0.29%
Deferred Tax Assets, Net of Valuation Allowance 14.5M USD -41.9%
Share-based Payment Arrangement, Expense 56.3M USD -8.62%
Interest Expense 11.6M USD -19.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%